Literature DB >> 11521212

Respiratory chain deficiency in Alpers syndrome.

M Gauthier-Villars1, P Landrieu, V Cormier-Daire, E Jacquemin, D Chrétien, A Rötig, P Rustin, A Munnich, P de Lonlay.   

Abstract

Alpers syndrome is a progressive encephalopathy of early onset, characterized by rapid and severe developmental delay, intractable seizures and liver involvement in a previously healthy child. Here, we report on respiratory chain enzyme deficiency in the liver of four unrelated children presenting with epileptic encephalopathy and liver involvement diagnosed as Alpers syndrome. Interestingly, oxidative phosphorylation in skeletal muscle was normal in 4/4 and blood and CSF lactate in 3/4 patients. Liver involvement had a late clinical onset in patients with previously isolated epileptic encephalopathy. Based on these observations, we suggest 1. to give consideration to respiratory chain deficiency in the diagnosis of severe epileptic encephalopathy in childhood, even when no clinical or biological evidence of liver involvement or lactic acidosis is noted, and 2. to investigate the respiratory chain in a needle biopsy of the liver in children with epileptic encephalopathy prior to valproate administration if biochemical indications for respiratory chain disease or hepatic disturbance are noted, as this drug is believed to occasionally trigger hepatic failure and fatal outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521212     DOI: 10.1055/s-2001-16614

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  9 in total

Review 1.  Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

Authors:  Linsheng Zhang; Sherine S L Chan; Daynna J Wolff
Journal:  Arch Pathol Lab Med       Date:  2011-07       Impact factor: 5.534

Review 2.  Alpers-Huttenlocher syndrome.

Authors:  Russell P Saneto; Bruce H Cohen; William C Copeland; Robert K Naviaux
Journal:  Pediatr Neurol       Date:  2013-03       Impact factor: 3.372

3.  Energetic, oxidative and ionic exchange in rat brain and liver mitochondria at experimental audiogenic epilepsy (Krushinsky-Molodkina model).

Authors:  Natalya I Venediktova; Olga S Gorbacheva; Natalia V Belosludtseva; Irina B Fedotova; Natalia M Surina; Inga I Poletaeva; Oleg V Kolomytkin; Galina D Mironova
Journal:  J Bioenerg Biomembr       Date:  2017-01-09       Impact factor: 2.945

Review 4.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 5.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 6.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

Review 7.  MtDNA-maintenance defects: syndromes and genes.

Authors:  Carlo Viscomi; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2017-03-21       Impact factor: 4.982

8.  Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency.

Authors:  Elise Vantroys; Joél Smet; Arnaud V Vanlander; Sarah Vergult; Ruth De Bruyne; Frank Roels; Hedwig Stepman; Herbert Roeyers; Björn Menten; Rudy Van Coster
Journal:  Orphanet J Rare Dis       Date:  2018-05-21       Impact factor: 4.123

9.  Mitochondrial mosaics in the liver of 3 infants with mtDNA defects.

Authors:  Frank Roels; Patrick Verloo; François Eyskens; Baudouin François; Sara Seneca; Boel De Paepe; Jean-Jacques Martin; Valerie Meersschaut; Marleen Praet; Emmanuel Scalais; Marc Espeel; Joél Smet; Gert Van Goethem; Rudy Van Coster
Journal:  BMC Clin Pathol       Date:  2009-06-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.